Literature DB >> 22467185

Does smoking influence Crohn's disease in the biologic era? The TABACROHN study.

Tiago Nunes1, Maria Josefina Etchevers, Olga Merino, Sonia Gallego, Valle García-Sánchez, Ignacio Marín-Jiménez, Luis Menchén, Manuel Barreiro-de Acosta, Guillermo Bastida, Sara García, Elena Gento, Daniel Ginard, Fernando Gomollón, Maite Arroyo, David Monfort, Esther García-Planella, Benito Gonzalez, Carme Loras, Carles Agustí, Carolina Figueroa, Miquel Sans.   

Abstract

BACKGROUND: While most studies have found a negative effect of smoking on Crohn's disease (CD) phenotype, more recent data have failed to reproduce this association, which might be due to a current wider use of thiopurines and biologic therapy. The TABACROHN study aimed at defining the impact of smoking on CD in the largest published series.
METHODS: This multicenter cross-sectional study included 1170 CD patients. Patients were classified as nonsmokers, current smokers, or former smokers according to their present smoking status. Clinical data regarding disease characteristics, treatment, and complications were collected.
RESULTS: Smokers were more frequently under maintenance treatment when compared to nonsmokers. In addition, current smokers presented higher use of biologic drugs compared to nonsmokers. Tobacco exposure and a higher tobacco load were independent predictors of need for maintenance treatment and stenosing phenotype, respectively.
CONCLUSIONS: In the era of early and widespread use of immunosuppressants and biologics, tobacco exposure is an independent predictor of need for maintenance treatment, specifically biologic therapy. The wider use of biologics and immunosuppressants could account for the existence of no major differences in disease behavior and complications between nonsmokers and current smokers.

Entities:  

Mesh:

Year:  2013        PMID: 22467185     DOI: 10.1002/ibd.22959

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  14 in total

1.  Association Between Long-term Oral Contraceptive Use and Risk of Crohn's Disease Complications in a Nationwide Study.

Authors:  Hamed Khalili; Fredrik Granath; Karin E Smedby; Anders Ekbom; Martin Neovius; Andrew T Chan; Ola Olen
Journal:  Gastroenterology       Date:  2016-02-23       Impact factor: 22.682

Review 2.  ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Authors:  Francis A Farraye; Gil Y Melmed; Gary R Lichtenstein; Sunanda V Kane
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

Review 3.  Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.

Authors:  Geoffrey C Nguyen; Shane M Devlin; Waqqas Afif; Brian Bressler; Steven E Gruchy; Gilaad G Kaplan; Liliana Oliveira; Sophie Plamondon; Cynthia H Seow; Chadwick Williams; Karen Wong; Brian M Yan; Jennifer Jones
Journal:  Can J Gastroenterol Hepatol       Date:  2014-05

4.  Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy.

Authors:  José Miranda-Bautista; Celia de Gracia-Fernández; María López-Ibáñez; María Barrientos; Alejandra Gallo-Moltó; Marina González-Arias; Casilda González-Gil; Alicia Díaz-Redondo; Ignacio Marín-Jiménez; Luis Menchén
Journal:  Dig Dis Sci       Date:  2015-02-14       Impact factor: 3.199

5.  Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.

Authors:  Tiago Nunes; Maria Josefina Etchevers; Valle García-Sánchez; Daniel Ginard; Eva Martí; Manuel Barreiro-de Acosta; Fernando Gomollón; Maite Arroyo; Guillermo Bastida; Benito Gonzalez; David Monfort; Esther García-Planella; Carolina Figueroa; Julián Panés; Miquel Sans
Journal:  Am J Gastroenterol       Date:  2016-02-09       Impact factor: 10.864

Review 6.  Modifiable Environmental Factors in Inflammatory Bowel Disease.

Authors:  Kristin E Burke; Christine Boumitri; Ashwin N Ananthakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2017-05

7.  Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA.

Authors:  Peiqi Wang; Jun Hu; Shadi Ghadermarzi; Ali Raza; Douglas O'Connell; Amy Xiao; Faraz Ayyaz; Min Zhi; Yuanqi Zhang; Nimisha K Parekh; Mark Lazarev; Alyssa Parian; Steven R Brant; Marshall Bedine; Brindusa Truta; Pinjin Hu; Rupa Banerjee; Susan M Hutfless
Journal:  Dig Dis Sci       Date:  2018-06-04       Impact factor: 3.199

Review 8.  Health Maintenance in Inflammatory Bowel Disease.

Authors:  Fazia A Mir; Sunanda V Kane
Journal:  Curr Gastroenterol Rep       Date:  2018-04-17

9.  The Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis.

Authors:  Alexandra D Frolkis; Jennifer de Bruyn; Nathalie Jette; Mark Lowerison; Jordan Engbers; William Ghali; James D Lewis; Isabelle Vallerand; Scott Patten; Bertus Eksteen; Cheryl Barnabe; Remo Panaccione; Subrata Ghosh; Samuel Wiebe; Gilaad G Kaplan
Journal:  Clin Transl Gastroenterol       Date:  2016-04-21       Impact factor: 4.488

10.  Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.

Authors:  María Chaparro; Ana Garre; Andrea Núñez Ortiz; María Teresa Diz-Lois Palomares; Cristina Rodríguez; Sabino Riestra; Milagros Vela; José Manuel Benítez; Estela Fernández Salgado; Eugenia Sánchez Rodríguez; Vicent Hernández; Rocío Ferreiro-Iglesias; Ángel Ponferrada Díaz; Jesús Barrio; José María Huguet; Beatriz Sicilia; María Dolores Martín-Arranz; Xavier Calvet; Daniel Ginard; Inmaculada Alonso-Abreu; Luis Fernández-Salazar; Pilar Varela Trastoy; Montserrat Rivero; Isabel Vera-Mendoza; Pablo Vega; Pablo Navarro; Mónica Sierra; José Luis Cabriada; Mariam Aguas; Raquel Vicente; Mercè Navarro-Llavat; Ana Echarri; Fernando Gomollón; Elena Guerra Del Río; Concepción Piñero; María José Casanova; Katerina Spicakova; Jone Ortiz de Zarate; Emilio Torrella Cortés; Ana Gutiérrez; Horacio Alonso-Galán; Álvaro Hernández-Martínez; José Miguel Marrero; Rufo Lorente Poyatos; Margalida Calafat; Lidia Martí Romero; Pilar Robledo; Orencio Bosch; Nuria Jiménez; María Esteve Comas; José María Duque; Ana María Fuentes Coronel; Manuela Josefa Sampedro; Eva Sesé Abizanda; Belén Herreros Martínez; Liliana Pozzati; Hipólito Fernández Rosáenz; Belén Crespo Suarez; Pilar López Serrano; Alfredo J Lucendo; Margarita Muñoz Vicente; Fernando Bermejo; José Joaquín Ramírez Palanca; Margarita Menacho; Amalia Carmona; Raquel Camargo; Sandra Torra Alsina; Nuria Maroto; Juan Nerín de la Puerta; Elena Castro; Ignacio Marín-Jiménez; Belén Botella; Amparo Sapiña; Noelia Cruz; José Luis F Forcelledo; Abdel Bouhmidi; Carlos Castaño-Milla; Verónica Opio; Isabel Nicolás; Marcos Kutz; Alfredo Abraldes Bechiarelli; Jordi Gordillo; Yolanda Ber; Yolanda Torres Domínguez; María Teresa Novella Durán; Silvia Rodríguez Mondéjar; Francisco J Martínez-Cerezo; Lilyan Kolle; Miriam Sabat; Cesar Ledezma; Eduardo Iyo; Óscar Roncero; Rebeca Irisarri; Laia Lluis; Isabel Blázquez Gómez; Eva María Zapata; María José Alcalá; Cristina Martínez Pascual; María Montealegre; Laura Mata; Ana Monrobel; Alejandro Hernández Camba; Luis Hernández; María Tejada; Alberto Mir; María Luisa Galve; Marta Soler; Daniel Hervías; José Antonio Gómez-Valero; Manuel Barreiro-de Acosta; Fernando Rodríguez-Artalejo; Esther García-Esquinas; Javier P Gisbert
Journal:  J Clin Med       Date:  2021-06-29       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.